Insiders · VXRT

VXRT insider transactions

Vaxart Inc (VXRT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VXRT

• 20d
  Director Watson W. Mark bought $6,530 worth of shares (10,000 units at $0.65), increasing direct ownership by 8% to 134,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 25d
  Chief Financial Officer Grasman Jeroen Nicolaas covered exercise/tax liability with 31,395 shares, decreasing direct ownership by 5% to 545,605 units (SEC Form 4) (tax liability)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 44d
  Director Breitmeyer James B was granted 78,800 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 44d
  SEC Form 3 filed by new insider Breitmeyer James B

  3 - Vaxart, Inc. (0000072444) (Issuer)
• 76d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 76d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 81d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 81d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 81d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 81d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 87d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 87d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 87d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 87d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Lo Steven

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Tucker Sean

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Grasman Jeroen Nicolaas

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Cummings James F.

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 88d
  SEC Form 4 filed by Berg Edward B

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 129d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 7,965 shares, decreasing direct ownership by 1% to 737,792 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 129d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 9,265 shares, decreasing direct ownership by 1% to 684,858 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 129d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 9,265 shares, decreasing direct ownership by 1% to 731,225 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 188d
  President, Chief Exec Officer Lo Steven was granted 151,351 shares and covered exercise/tax liability with 54,153 shares, increasing direct ownership by 6% to 1,787,559 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 191d
  Director Watson W. Mark bought $8,185 worth of shares (20,000 units at $0.41), increasing direct ownership by 19% to 124,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 206d
  Director Heron Elaine J bought $15,921 worth of shares (40,000 units at $0.40), increasing direct ownership by 71% to 96,566 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 300d
  Director Finney Kevin bought $61,934 worth of shares (166,668 units at $0.37), increasing direct ownership by 437% to 204,771 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 318d
  Director Watson W. Mark bought $4,050 worth of shares (10,000 units at $0.41), increasing direct ownership by 11% to 104,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 363d
  Director Finney Kevin was granted 6,103 shares, increasing direct ownership by 19% to 38,103 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 363d
  Director Watson W. Mark was granted 16,000 shares, increasing direct ownership by 20% to 94,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 363d
  Director Heron Elaine J was granted 16,000 shares, increasing direct ownership by 39% to 56,566 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 363d
  Director Wheadon David E. was granted 16,000 shares, increasing direct ownership by 52% to 46,750 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 363d
  Director Finney Michael J. was granted 16,000 shares, increasing direct ownership by 2% to 702,840 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 391d
  Chief Financial Officer Grasman Jeroen Nicolaas was granted 350,000 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 391d
  SEC Form 3 filed by new insider Grasman Jeroen Nicolaas

  3 - Vaxart, Inc. (0000072444) (Issuer)
• 391d
  President, Chief Exec Officer Lo Steven bought $49,000 worth of shares (100,000 units at $0.49) (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 439d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 3,292 shares, decreasing direct ownership by 0.44% to 745,757 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 440d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 3,913 shares, decreasing direct ownership by 0.53% to 740,490 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 445d
  President, Chief Exec Officer Lo Steven was granted 1,405,000 shares, increasing direct ownership by 617% to 1,632,638 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 445d
  SVP, Chief Scientific Officer Tucker Sean was granted 406,000 shares, increasing direct ownership by 120% to 744,403 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 445d
  Chief Financial Officer Lee Phillip E was granted 406,000 shares, increasing direct ownership by 180% to 631,619 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 445d
  Chief Medical Officer Cummings James F. was granted 406,000 shares, increasing direct ownership by 118% to 749,049 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 445d
  SVP, General Counsel Berg Edward B was granted 406,000 shares, increasing direct ownership by 141% to 694,123 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 451d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 3% to 288,123 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 451d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 10,039 shares, decreasing direct ownership by 3% to 343,049 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 451d
  President, Chief Exec Officer Lo Steven covered exercise/tax liability with 22,362 shares, decreasing direct ownership by 9% to 227,638 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 451d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 2% to 338,403 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 451d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 8,050 shares, decreasing direct ownership by 3% to 225,619 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 495d
  SVP, Chief Scientific Officer Tucker Sean covered exercise/tax liability with 9,242 shares, decreasing direct ownership by 3% to 346,453 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 495d
  Chief Medical Officer Cummings James F. covered exercise/tax liability with 7,964 shares, decreasing direct ownership by 2% to 318,837 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 495d
  SVP, General Counsel Berg Edward B covered exercise/tax liability with 9,242 shares, decreasing direct ownership by 3% to 261,464 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 501d
  Director Finney Kevin was granted 32,000 shares (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 501d
  SEC Form 3 filed by new insider Finney Kevin

  3 - Vaxart, Inc. (0000072444) (Issuer)
• 544d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 6,132 shares, decreasing direct ownership by 3% to 233,669 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 725d
  Director Watson W. Mark bought $13,578 worth of shares (20,000 units at $0.68), increasing direct ownership by 34% to 78,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 732d
  Chief Financial Officer Lee Phillip E covered exercise/tax liability with 2,007 shares, decreasing direct ownership by 0.83% to 239,801 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Director Wheadon David E. was granted 16,000 shares, increasing direct ownership by 108% to 30,750 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Director Finney Michael J. was granted 16,000 shares, increasing direct ownership by 2% to 686,840 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Director Heron Elaine J was granted 16,000 shares, increasing direct ownership by 65% to 40,566 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Director Watson W. Mark was granted 16,000 shares, increasing direct ownership by 38% to 58,125 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)
• 733d
  Director Yedid Robert A. was granted 16,000 shares, increasing direct ownership by 87% to 34,490 units (SEC Form 4)

  4 - Vaxart, Inc. (0000072444) (Issuer)